BCL6-IN-3
Modify Date: 2025-08-29 11:40:33
BCL6-IN-3 structure
|
Common Name | BCL6-IN-3 | ||
|---|---|---|---|---|
| CAS Number | 2253878-44-1 | Molecular Weight | 508.99 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H31ClF2N6O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BCL6-IN-3BCL6-IN-3 (example 20a) is a B-cell lymphoma 6 (BCL6) inhibitor with anti-tumor activity, extracted from patent WO2018215801A1. BCL6-IN-3 (example 20a) exhibits a GI50 of 70 nM in SU-DHL4 cells[1]. |
| Name | BCL6-IN-3 |
|---|
| Description | BCL6-IN-3 (example 20a) is a B-cell lymphoma 6 (BCL6) inhibitor with anti-tumor activity, extracted from patent WO2018215801A1. BCL6-IN-3 (example 20a) exhibits a GI50 of 70 nM in SU-DHL4 cells[1]. |
|---|---|
| Related Catalog | |
| Target |
GI50: 70 nM (SU-DHL4 cells proliferation)[1]. |
| References |
[1]. Benjamin Richard, et al. BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6. Patent. WO2018215801A1. |
| Molecular Formula | C24H31ClF2N6O2 |
|---|---|
| Molecular Weight | 508.99 |